Guangdong Biolight Meditech Co Ltd
SZSE:300246
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guangdong Biolight Meditech Co Ltd
Additional Paid In Capital
Guangdong Biolight Meditech Co Ltd
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Guangdong Biolight Meditech Co Ltd
SZSE:300246
|
Additional Paid In Capital
¥408.1m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
88%
|
CAGR 10-Years
14%
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Additional Paid In Capital
¥702.6m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Additional Paid In Capital
¥1.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
61%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Additional Paid In Capital
¥6.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Additional Paid In Capital
¥1.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
16%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Additional Paid In Capital
¥14B
|
CAGR 3-Years
0%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Guangdong Biolight Meditech Co Ltd
Glance View
Guangdong Biolight Meditech Co., Ltd. engages in the research, development, production, sale, and service of medical device products. The company is headquartered in Zhuhai, Guangdong and currently employs 1,335 full-time employees. The company went IPO on 2011-07-19. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The firm distributes its products in domestic and overseas markets.
See Also
What is Guangdong Biolight Meditech Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
408.1m
CNY
Based on the financial report for Sep 30, 2025, Guangdong Biolight Meditech Co Ltd's Additional Paid In Capital amounts to 408.1m CNY.
What is Guangdong Biolight Meditech Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
14%
Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Guangdong Biolight Meditech Co Ltd have been -7% over the past three years , 88% over the past five years , and 14% over the past ten years .
